Practical Tools to Successfully Taper Prescription Opioids. Melissa Weimer, DO, MCR

Similar documents
Difficult Conversations

Conversations As Medicine Compassion-Based Difficult Conversations

Opioids for Pain Treatment in Persons with Opioid Use Disorder. Patricia Pade, MD Seddon R. Savage, MD, MS Melissa Weimer, DO, MCR

2/7/2017. Avoid compassion traps. Avoid All or Nothing Traps. Some Explanatory Models of Addiction

MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER Melissa B. Weimer, DO, MCR Chief of Behavioral Health & Addiction Medicine St.

Tapering Opioids Best Practices*

Opioid Review and MAT Clinic CDC Guidelines

Pain Management Wrap-Up Chronic Care. David Tauben, MD Medicine Anesthesia & Pain Medicine

Opiate Use Disorder and Opiate Overdose

An overview of Medication Assisted Treatment (MAT) and acute pain management on MAT

ten questions you might have about tapering (and room for your own) an informational booklet for opioid pain treatment

Subject: Pain Management (Page 1 of 7)

10 mg hydrocodone equals how much oxycodone

Managing Pain in the Patient with Opioid Use Disorder: Inpatient Management. Melissa Weimer, DO, MCR Oregon Health & Science University

Opioid Pharmacology and Dosing Management

Best Practices in Prescribing Opioids for Chronic Non-cancer Pain

Methadone Maintenance 101

HOPE. Considerations. Considerations ISING. Safe Opioid Prescribing Guidelines for ACUTE Non-Malignant Pain

Canadian Guideline for Opioids for Chronic Non-Cancer Pain. Speaker Disclosure. Objectives. Canadian Guideline for Opioids for Chronic Non-Cancer Pain

Managing Pain in Individuals with Serious Illness and Comorbid Substance Use Disorder

Acute pain management in opioid tolerant patients. Muhammad Laklouk

Opioid Management of Chronic (Non- Cancer) Pain

Prescribing drugs of dependence in general practice, Part C

6/27/2017. Disclosures. Overview. Case Overview

Welcome - we will begin the webinar shortly Please read the participation tips below:

Analgesics: Management of Pain In the Elderly Handout Package

MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER

Substitution Therapy for Opioid Use Disorder The Role of Suboxone

Equianalgesic Dosing: Making Opioid Interchange Easier. Joseph Bubalo PharmD, BCPS, BCOP Oncology Clinical Pharmacist Assistant Professor Of Medicine

Buprenorphine 2.0: I have my waiver, now what? Dr. Ritu Bhatnagar, M.D., M.P.H. Dr. John Ewing, M.D., FASAM. Disclosures

Basics of Benzodiazepine Use Disorder. DATE: October 3, 2017 PRESENTED BY: Melissa B. Weimer, DO, MCR

Opioid Use Disorder Treatment: Buprenorphine Treatment Basics

Pain management. Coleman Palliative Care Conference: February 2016 Josh Baru MD Stacie Levine MD

Universal Precautions and Opioid Risk. Assessment. Questions: How often do you screen your patients for risk of misuse when prescribing opioids?

CDC Guideline for Prescribing Opioids for Chronic Pain

Canadian Guideline for Opioids for Chronic Non-Cancer Pain. Speaker Disclosure. Objectives. Canadian Guideline for Opioids for Chronic Non-Cancer Pain

Knock Out Opioid Abuse in New Jersey:

Treatment of Pain in an Emergent Setting

Objectives. When to Refer. PISA Physicians 1/25/17. Financial Disclosures: None. PISA & THMEP January 28, 2017 Kenneth B. Gossler M.D.

CDC Guideline for Prescribing Opioids for Chronic Pain. Centers for Disease Control and Prevention National Center for Injury Prevention and Control

Medication Assisted Treatment. Nicole Gastala, MD

Basics of Benzodiazepine Use Disorder. DATE: June 12, 2018 PRESENTED BY: Melissa B. Weimer, DO, MCR

Disclosures. Topics of today s training 4/24/2017. Evolving Treads in Medication Assisted Treatment. Christopher J Davis D.O.

Overview of Essentials of Pain Management. Updated 11/2016

1/30/2017 SEISMIC UPGRADE FOR THE OPIOID PARADIGM SHIFT ACPE PRE-TEST QUESTIONS. I have no declarations.

New Guidelines for Opioid Prescribing

Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention

OPIOID USE DISORDER AND THE PSYCHIATRIC EMERGENCY ROOM THE VA CT MODEL

Medication-Assisted Treatment. What Is It and Why Do We Use It?

Fighting the Good Fight: How to Convert Opioids Just Right!

Addiction to Opioids. Marvin D. Seppala, MD Chief Medical Officer

9/13/2017. Buprenorphine Treatment (Suboxone) Disclosures. We ve Got a Big Opioid Problem. Selahattin Kurter, MD Spectrum Healthcare

Chronic Pain, Opioids, & Addiction: Assessing and Managing Risk

OAT Transitions - focus on microdosing. Mark McLean MD MSc FRCPC CISAM DABAM

Prescription Opioids

D. Janene Holladay, M.D. Board Certifications: American Board of Anesthesiology American Board of Pain Medicine American Board of Addiction Medicine

Opioid Prescribing Tips & Tricks CANDY STOCKTON, MD MAY 2018

USE OF BUPRENORPHINE FOR CHRONIC PAIN

Ken Roy, MD, FASAM. The Opioid Epidemic and Addiction Involving the Use of Opioids. Tulane & LSU Department of Psychiatry

Basics of Benzodiazepine Use Disorder. DATE: March 20, 2018 PRESENTED BY: Melissa B. Weimer, DO, MCR

MAT IN PREGNANCY KAYLA LIFE STAGE 1: ADOLESCENCE LIFE STAGE 2: EARLY ADULTHOOD. family History of addiction. addiction to oral opioids

The Prescription Review Program and College Expectations. Dr. Rashmi Chadha MBChB MScCH CCFP MRCGP Dip. ABAM

NBPDP Drug Utilization Review Process Update

New Guidelines for Prescribing Opioids for Chronic Pain

IMPLEMENTATION OF A SHARED MEDICAL APPOINTMENT FOR OPIOID OVERDOSE EDUCATION AND NALOXONE KIT TRAINING FOR VETERANS Kristin A. Tallman, Pharm.

Charles P. O Brien, MD, PhD University of Pennsylvania No financial conflicts, patents, speakers bureaus

FY17 SCOPE OF WORK TEMPLATE. Name of Program/Services: Medication-Assisted Treatment: Buprenorphine

NALTREXONE DAVID CRABTREE, MD, MPH UNIVERSITY OF UTAH HEALTH, 2018

Opioid Pearls and Acute Pain Management

Medication Assisted Treatment. Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Department of Veterans Affairs

PAIN MANAGEMENT PGY-1. Aaron D. Storms, MD Carin van Zyl, MD Adult and Pediatric Palliative Care, LAC+USC Keck School of Medicine of USC

Opioids Research to Practice

Appendix 1. University of Minnesota Amplatz Children s Hospital Opioid Weaning Guideline

Rule Governing the Prescribing of Opioids for Pain

The Oregon Opioid Initiative. State Pain & Opioid Conference Prescription Drug Monitoring May 2018 Lisa Millet, Public Health Division

Opioids Research to Practice

THE PROS & CONS OF THE CDC GUIDELINES FOR SAFE OPIOID PRESCRIBING

Revised 9/30/2016. Primary Care Provider Pain Management Toolkit

Opioid Tapering and Withdrawal Guidance

5/10/17. Back to Basics: The Role of Chronic Opioids for Chronic Pain. Thomas B. Gregory, PharmD, BCPS, FASPE, CPE. Disclosures. Nothing to disclose

Proposed Revision to Med (i)

The Difficult Patient: Risk Mitigation Strategies

POLYSUBSTANCE USE IN THE TREATMENT OF OPIOID USE DISORDER WITH BUPRENORPHINE

Department of Veterans Affairs Network Policy No.: VA Desert Pacific Healthcare Network (VISN 22) Date: September 23, 2014 Long Beach, CA

15mg oxycodone is equivalent to how much morphine

Safe and Competent Opioid Prescribing

Disclosures. Ms. Walsh has nothing to disclose Ms. Broglio is on the speaker s bureau for Genentech and Meda Pharmaceuticals

Substance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates

3. Has the patient had a sustained improvement in Pain or Function (e.g. PEG scale with a 30 percent response from baseline)?

What Is Heroin? Examples of Opioids. What Science Says about Opioid Use Disorder and Its Treatment 6/27/2016

Prescription Opioid Addiction

Buprenorphine pharmacology

Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction

Clinical Guidelines for the Pharmacologic Treatment of Opioid Use Disorder

Problematic opioid need in chronic pain: Part 2: Complex persistent dependence and the confusing patient experience on and off opioids

(Adapted with permission from the D-H Knowledge Map Primary Care Buprenorphine Guidelines)

Pain Management and Safe use of opioids in hospitals. Kyoung-Sil Kang, PharmD, BCPS Scott Tam, PharmD Lauve Casimir, RN, MSN

Take Home Naloxone elearning Module Script

Welcome to the Opioid Overdose Prevention Project

Changing Course: statewide efforts to combat the opioid epidemic in California

Transcription:

Practical Tools to Successfully Taper Prescription Opioids Melissa Weimer, DO, MCR

Objectives Understand how to calculate morphine equivalents per day Understand the steps necessary to plan a successful opioid taper Describe several opioid taper case scenarios

Step 1: Identify Reason for the Opioid Taper Substance Use Disorder including opioid use disorder (OUD), alcohol use disorder, etc Diversion At risk for severe opioid harms Aspiration, hypoxia, bowel obstruction, overdose, etc Refusing monitoring (urine drug testing, abstain from marijuana or alcohol, etc) At risk for less severe opioid harms (>50 90 MED, benzos) High dose long term use of prescription opioids without OUD Concomitant benzodiazepines Sleep apnea Therapeutic Failure Persistently high pain, opioid induced hyperalgesia, reduced functional status

Prescription Opioid use disorder diagnosis may be difficult to make in patients prescribed long term opioids For the illicit opioid user Procurement behaviors and consequences For the patient with pain much more complex Enduring adaptation produced by established behaviors Continuous prescribed opioid therapy prevents opioid seeking Memory of pain, pain relief and possibly also euphoria Even if the opioid seeking appears as seeking pain relief, it becomes an adaptation that is difficult to reverse It is hard to distinguish drug seeking from relief seeking Ballantyne JC, et al. New addiction criteria: Diagnostic challenges persist in treatment pain with opioids. IASP: Pain Clinical updates, Dec 2013.

Step 2: Calculate the Morphine Equivalent Dose **DO NOT USE FOR OPIOID ROTATION** Second option Methadone 4.7* *Neilsen, et al

CALCULATE THE MED (or MME ) AMDG on-line calculator www.agencymeddirectors.wa.gov Opioid Dose Calculator Methadone 1-20 mg 4x 21-40 mg 8x 41-60 mg 10x >61-80 mg 12x

Calculating Morphine Equivalent Dose Fentanyl 25mcg/hr patch 25 x 2.4 conversion factor (CF) = 60mg MED Hydromorphone 2mg every 4 hours + Oxycodone 60mg BID 2mg x 6 = 12mg x 4 CF = 48mg MED 60mg x 2 = 120mg x 1.5 CF = 180mg MED TOTAL 228mg MED Methadone 20mg TID 20mg x 3 = 60mg x 10.0* CF = 600mg MED

Step 3: Taper plan and start taper Discuss goals of taper how and when will you know if it is successful? Establish dose target and timeframe Maintain current level of analgesia (may not be possible in short term) Discuss potential opioid withdrawal symptoms Temporary increase in pain Schedule follow up or nurse check ins Identify at least one self management goal

How to approach an opioid taper/cessation Indication for Taper Recommended Length of Taper Degree of Shared Decision Making about Taper Intervention/Setting Substance Use Disorder No taper, immediate referral None provider choice alone Intervention: Transition to medication assisted treatment (MAT, ie. buprenorphine or methadone) for OUD, Naloxone rescue kit Setting: Detox, inpatient or outpatient treatment with MAT Diversion No taper to rapid taper (days) None provider choice alone Determine need based on actual use of opioids, if any At risk for severe harms Weeks Moderate provider led & patient views sought Intervention: Supportive care Naloxone rescue kit Setting: Outpatient opioid taper or inpatient withdrawal management Option: Buprenorphine (OBOT) Therapeutic failure Months to year Moderate provider led & patient views sought Intervention: Supportive care Naloxone rescue kit Setting: Outpatient opioid taper Option: Buprenorphine (OBOT) At risk for less severe harms Months to Years Moderate provider led & patient views sought Intervention: Supportive care Naloxone rescue kit Setting: Outpatient opioid taper Option: Buprenorphine (OBOT)

ALWAYS Use a Risk Benefit Framework NOT Is the patient good or bad? Does the patient deserve opioids? Should this patient be punished or rewarded? Should I trust the patient? Judge the opioid treatment NOT the patient RATHER Do the benefits of opioid treatment outweigh the untoward effects and risks for this patient (or society)? Nicolaidis C. Pain Med. 2011 Jun;12(6):890 7.

Outpatient Tapering Options Gradual taper: 5 10% decreases of the original dose every 5 28 days Once 30% of the original dose is reached, then decrease each taper step by 10% of the remaining dose every 5 28 days You may elect to taper Extended release (ER) or Immediate release (IR) first generally taper ER first and use IR for breakthrough pain Provide the patient a copy of the taper plan for reference and to help keep patient moving forward 12

Outpatient Tapering Options Rapid taper: Daily to every other day reductions over 1 2 weeks as appropriate Medication assisted taper: Adjuvant opioid withdrawal medications only Office based buprenorphine withdrawal assistance (i.e. detox) or maintenance transition Referral for Methadone maintenance treatment 13

Medication Assisted Treatment Some patients will be unable or intolerant of taper Methadone >30mg MED >200mg Long term use > 5 years Mental illness, history of adverse childhood experiences (ACEs), history of substance use disorder, poor social supports Buprenorphine/naloxone is an important resource for these patients Interdisciplinary pain programs +/ MAT have good outcomes Huffman, et al. Opioid use 12 months following interdisciplinary pain rehab with weaning. Pain Med 2013; 14 (12):1908 1917.

Case 1: Severe Risks 50 yo man on opioids for LBP x 5 years develops severe constipation with small bowel obstruction due to opioid use. You decide the severe risks outweigh the small benefit of him remaining on morphine ER 15mg BID Taper Plan: Step 1: convert his morphine to IR and reduce it to morphine IR 7.5mg Q8H for 2 weeks Step 2: Reduce morphine IR 7.5mg BID for 2 weeks Step 3: Morphine IR 7.5mg daily for 2 weeks Step 4: stop morphine

Case 1: Severe Risks What if that same 50 yo man on opioids for LBP x 5 years is prescribed fentanyl 75mcg/72 hours. Taper Plan: Step 1: convert his fentanyl to a different opioid that is easier to taper like morphine ER or oxycodone ER. Ex. Morphine ER 45mg/30mg/30mg. Step 1: Morphine ER 30/30/30mg TID x 2 weeks 1 month Step 2: Continue in 10 20% reductions until done

Case 2: Substance Use Disorder 50 yo male prescribed hydromorphone 4mg every 3 hours and fentanyl 50mcg patch for chronic pancreatitis. You detect alcohol on a routine urine drug screening, and he admits that he has relapsed on alcohol. What do you do? Decide that the risks greatly outweigh the benefit Refer for detoxification from alcohol and opioids Stop prescribing opioids immediately Consider buprenorphine/naloxone, if alcohol abstinent

Case 3 28 yo female prescribed opioids for chronic abdominal pain. She states she has lost her opioid prescription for the third time. She has had two negative urine drug tests for the opioid that is prescribed and refuses to come in for a pill count. You suspect diversion. Check PDMP Taper Plan: None. You stop prescribing opioids immediately.

Case 4: Lost Generation with therapeutic alliance 68 yo female with rheumatoid arthritis pain. She is prescribed a total of 350mg MED for the last 5 years with no adverse events. She is moderately functional. Your clinic has developed a new opioid policy stating that patients prescribed doses >120mg MED need to attempt an opioid taper. She is concerned that she might develop serious harms from her opioids. Taper plan: Slow taper by 10% per month over a year to a safer dose. May elect to slow down the taper if she experiences periods of worsening pain and/or opioid withdrawal. If her disease continues to generate active nociceptive pain not controlled with DMARDs, she may well be a candidate for long term opioids, but at a safer dose.

Case 5: Lost Generation with Hopelessness 63 yo man with history of low back pain and severe depression after a work injury in 1982. He has not worked since and spends most of his day being sedentary. He has been unwilling to engage in additional pain modalities despite multiple offers. He is prescribed oxycodone IR 30mg every 4 hours. You have tried other opioids but he has not had improvements. He refuses an opioid taper and states he will seek another provider if you start to taper his opioids. Taper Plan: Offer buprenorphine, subacute detox program, OR a 1 month rapid opioid taper

Questions? weimerm@ohsu.edu @DrMelissaWeimer www.coperems.org www.scopeofpain.com www.pcsso.org www.pcssmat.org UW Pain Provider Toolkit: http://depts.washington.edu/anesth/care/pain/index.shtml